Research Article
[Retracted] Nomogram to Predict Overall and Cancer-Specific Survival in Patients with Synovial Sarcoma in the Extremities: A Population-Based Study
Table 3
Univariate and multivariate analysis of CSS in the training cohort.
| Characteristics | Univariate analysis HR (95% CI) | P | Multivariate analysis HR (95% CI) | P |
| Age | 1.98 (1.07–3.69) | 0.03 | 2.05 (1–4.19) | 0.049 | 0–23 | 24–40 | >40 |
| Sex | 0.39 (0.15–1.02) | 0.056 | 0.49 (0.18–1.33) | 0.161 | Male | Female |
| Pathological type | 1.22 (0.78–1.91) | 0.391 | NA | NA | Spindle cell | Epithelioid cell | Biphasic |
| Primary site | 2.91 (0.67–12.58) | 0.154 | 1.02 (0.2–5.33) | 0.979 | Upper | Lower |
| Tumor size (mm) | 1.93 (1.09–3.42) | 0.024 | 1.26 (0.53–3) | 0.602 | 6–66 | 67–145 | >145 |
| Stage T | 1.36 (0.9–2.04) | 0.142 | 1 (0.55–1.81) | 0.995 | T1a | T1b | T2a | T2b | TX |
| Stage N | 3.22 (1.09–9.52) | 0.035 | 1.65 (0.44–6.24) | 0.459 | N0 | N1 | NX |
| Stage M | 14.85 (5.81–37.93) | 0 | 7.69 (2.49–23.7) | 0.001 | M0 | M1 |
| Radiation | 1.54 (0.6–3.91) | 0.368 | NA | NA | Yes | No |
| Chemotherapy | 0.25 (0.08–0.74) | 0.013 | 0.57 (0.15–2.19) | 0.411 | Yes | No |
| Surgery | 15.49 (3.23–74.3) | 0.001 | 6.74 (1.1–41.1) | 0.038 | Yes | No |
|
|